EWA
LKFT

EverSource Wealth Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

EverSource Wealth Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$959 Sell
32
-409
-93% -$11.6K ﹤0.01% 3977
2026
Q1 		$13.2K Buy
441
+409
+1,278% +$13.5K ﹤0.01% 2765
2025
Q4 		$1.05K Sell
32
-277
-90% -$8.94K ﹤0.01% 3697
2025
Q3 		$10.7K Sell
309
-99
-24% -$3.17K ﹤0.01% 2791
2025
Q2 		$11.4K Buy
+408
New +$10.9K ﹤0.01% 2724
2024
Q4 		– Sell
-32
Closed -$921 – 3776
2024
Q3 		$921 Hold
32
– – ﹤0.01% 2746
2024
Q2 		$853 Sell
32
-98
-75% -$2.78K ﹤0.01% 2769
2024
Q1 		$3.7K Buy
+130
New +$4.83K ﹤0.01% 2181

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

EverSource Wealth Advisors's LKFT Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 93% in Q2 2026, selling an estimated $11.6K and leaving 32 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #3977.

EverSource Wealth Advisors first reported a position in LKFT in Q1 2024 and has held it in 8 quarters since. The position peaked at $13.2K in Q1 2026. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • EverSource Wealth Advisors held 32 shares of Lakefront Biotherapeutics American Depositary Shares worth $959 as of Q2 2026.
  • EverSource Wealth Advisors sold 409 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $11.6K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3977 holding.
  • EverSource Wealth Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2024 and has held it in 8 quarters since.
  • EverSource Wealth Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $13.2K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.